 "Paradeep Phosphates IPO scrapes through on Day 3; issue subscribed 1.75x")
The Rs 1,500-crore initial public offering (IPO) of Paradeep Phosphates managed to scrape through despite challenging market conditions.
The issue, which closed on Thursday, managed to garner 1.75 times subscription.
The retail investor portion of the issue was subscribed 1.37 times, high-networth individual (HNI) portion was covered 82 per cent and institutional investor category saw three times subscription.
Paradeep Phosphates is India’s second-largest private sector manufacturer of phosphatic fertilizers.
The company raised Rs 1,004 crore fresh capital through the IPO and the remaining for secondary share sale. The price band for the issue was Rs 39-42 per share. At the top-end, the company is valued at Rs 3,421 crore.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%